By Editor

I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…

Search Stock Profiles

Latest News

NVDA: Nvidia Stock – Time to Buy or Sell This AI Rockstar?

Nvidia (NVDA) is the electrifying frontman of the tech scene, rocking the AI and semiconductor stage…

By Editor

VRTX: Vertex Pharmaceuticals – Buy or Sell This Biotech Beast?

Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market…

By Editor

MSFT: Microsoft Stock – Buy or Sell This Tech Titan?

Microsoft (MSFT) is the chill tech uncle you secretly admire, vibing at $393.08 (MacroTrends) as of…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

How Retail Investors Outplayed Wall Street in April

Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…

By Editor

The Auction Heard ‘Round Wall Street

Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…

By Editor

BNTX: BioNTech – Buy or Sell This Biotech Trailblazer?

BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…

By Editor
2 Min Read

REGN: Regeneron Pharmaceuticals – Buy or Sell This Biotech Brainiac?

Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…

By Editor
2 Min Read

The Biotech Bonanza: A Wild Ride Through the Stock Market Jungle

Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle gym of thrills, spills,…

By Editor
7 Min Read